6:32 am AVEO Pharma and Biodesix partner to co-develop and commercialize ficlatuzumab with a companion diagnostic for treatment of NSCLC – HedgeChatter

6:32 am AVEO Pharma and Biodesix partner to co-develop and commercialize ficlatuzumab with a companion diagnostic for treatment of NSCLC

11 Apr

6:32 am AVEO Pharma and Biodesix partner to co-develop and commercialize ficlatuzumab with a companion diagnostic for treatment of NSCLC

Bystocknews AVEO, stock Comments Off

View todays social media effects on AVEO

View the latest stocks trending across Twitter. Click to view dashboard

See who AVEO is hiring next, click here to view

Author